bluebird bio Inc BLUE
$4.97
Last Updated: May 30, 12:00 AM·LSE
Pricing for GB stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is bluebird bio Inc Stock Halal?
Shariah Compliance Analysis of BLUE Stock
United Kingdom Health Care Nano Cap No. As of September 2026, bluebird bio Inc (BLUE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. bluebird bio Inc does not pass Musaffa's business and financial screening criteria.
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. The company is headquartered in Somerville, Massachusetts and currently employs 248 full-time employees. The company went IPO on 2013-06-19. The firm is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The company markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs).
BLUE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, bluebird bio Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
bluebird bio Inc (BLUE) Chart
Financial Metrics & Statements of bluebird bio Inc (BLUE)
FAQ's for bluebird bio Inc (BLUE)
- As of September 2026, bluebird bio Inc BLUE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes bluebird bio Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in bluebird bio Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of bluebird bio Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of bluebird bio Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of bluebird bio Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for bluebird bio Inc (BLUE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
